Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study
- DOI
- 10.21037/tbcr-2025-1-81
- Published
- 2026-04
- Container
- Translational Breast Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tbcr-2025-1-81,
title = {Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study},
author = {Tao Wang and Yuping Sun and Wenyan Chen and Wei Li and Jing Cheng and Man Li and Zhongyu Yuan and Jun Qian and Kun Wang and Shu Wang and Huihua Xiong and Zhigang Yu and Xiaojia Wang and Chunjiao Wu and Micah J. Maxwell and Biao Zhang and Chang Liu and Xiaoling Zeng and Zefei Jiang},
year = {2026},
journal = {Translational Breast Cancer Research},
doi = {10.21037/tbcr-2025-1-81},
url = {https://doi.org/10.21037/tbcr-2025-1-81}
}RIS
TY - JOUR TI - Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study AU - Tao Wang AU - Yuping Sun AU - Wenyan Chen AU - Wei Li AU - Jing Cheng AU - Man Li AU - Zhongyu Yuan AU - Jun Qian AU - Kun Wang AU - Shu Wang AU - Huihua Xiong AU - Zhigang Yu AU - Xiaojia Wang AU - Chunjiao Wu AU - Micah J. Maxwell AU - Biao Zhang AU - Chang Liu AU - Xiaoling Zeng AU - Zefei Jiang PY - 2026 JO - Translational Breast Cancer Research DO - 10.21037/tbcr-2025-1-81 UR - https://doi.org/10.21037/tbcr-2025-1-81 ER -
APA
Wang, T., Sun, Y., Chen, W., Li, W., Cheng, J., Li, M., Yuan, Z., Qian, J., Wang, K., Wang, S., Xiong, H., Yu, Z., Wang, X., Wu, C., Maxwell, M. J., Zhang, B., Liu, C., Zeng, X., & Jiang, Z. (2026). Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study. Translational Breast Cancer Research. https://doi.org/10.21037/tbcr-2025-1-81
Source records
- crossref · retrieved 2026-09-25T22:53:02.433Z